Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07380412

A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Outliers, Inc. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTStasis Daytime and NighttimeDaytime taken with stimulant medication and food. Nighttime taken 30 minutes before bedtime on an empty stomach.
DIETARY_SUPPLEMENTPlaceboMatched placebo product in taste and appearance.

Timeline

Start date
2025-08-12
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2026-02-02
Last updated
2026-02-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07380412. Inclusion in this directory is not an endorsement.

A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications (NCT07380412) · Clinical Trials Directory